Cameron Turtle, DPhil
CEO, Spyre TherapeuticsDr Turtle is Chief Executive Officer for Spyre Therapeutics.
An experienced leader in the biotech space, he has advanced biopharma organizations from preclinical development to late-stage clinical trials and commercialization. Prior to joining Spyre, he served as Venture Partner at Foresite Labs and Chief Strategy Officer at BridgeBio Pharma. Prior to his work with BridgeBio, he led business development, investor relations, and multiple operational functions as the Chief Business Officer for Eidos Therapeutics. Before joining Eidos, he was a consultant for McKinsey & Company, where he developed strategies for M&A, growth, clinical trials, and sales force optimization for a variety of pharmaceutical and medical device companies.
Dr Turtle holds a BS from the University of Washington and a DPhil from the University of Oxford, St. John’s College.